{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:12:30Z","timestamp":1791357150996,"version":"4.3.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T00:00:00Z","timestamp":1355184000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/tp.2012.124","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T09:39:59Z","timestamp":1355218799000},"page":"e202-e202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":294,"title":["A randomised controlled trial of bumetanide in the treatment of autism in children"],"prefix":"10.1038","volume":"2","author":[{"given":"E","family":"Lemonnier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Degrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Phelep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Tyzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Josse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Grandgeorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Hadjikhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Ben-Ari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,11]]},"reference":[{"key":"BFtp2012124_CR1","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1111\/j.1651-2227.2010.01933.x","volume":"99","author":"E Lemonnier","year":"2010","unstructured":"Lemonnier E, Ben-Ari Y . The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects. Acta Paediatr 2010; 99: 1885\u20131888.","journal-title":"Acta Paediatr"},{"key":"BFtp2012124_CR2","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1001\/jama.2011.1638","volume":"306","author":"E Courchesne","year":"2011","unstructured":"Courchesne E, Mouton PR, Calhoun ME, Semendeferi K, hrens-Barbeau C, Hallet MJ et al. Neuron number and size in prefrontal cortex of children with autism 1. JAMA 2011; 306: 2001\u20132010.","journal-title":"JAMA"},{"key":"BFtp2012124_CR3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/aur.1239","volume":"5","author":"NZ Khan","year":"2012","unstructured":"Khan NZ, Gallo LA, Arghir A, Budisteanu B, Budisteanu M, Dobrescu I et al. Autism and the grand challenges in global mental health. Autism Res 2012; 5: 156\u2013159.","journal-title":"Autism Res"},{"key":"BFtp2012124_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/aur.239","volume":"5","author":"M Elsabbagh","year":"2012","unstructured":"Elsabbagh M, Divan G, Koh YJ, Kim YS, Kauchali S, Marcin C et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res 2012; 5: 160\u2013179.","journal-title":"Autism Res"},{"key":"BFtp2012124_CR5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/BF02172145","volume":"24","author":"C Lord","year":"1994","unstructured":"Lord C, Rutter M, Le CA . Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994; 24: 659\u2013685.","journal-title":"J Autism Dev Disord"},{"key":"BFtp2012124_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1023\/A:1005592401947","volume":"30","author":"C Lord","year":"2000","unstructured":"Lord C, Risi S, Lambrecht L, Cook EH, Leventhal BL, DiLavore PC et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 2000; 30: 205\u2013223.","journal-title":"J Autism Dev Disord"},{"key":"BFtp2012124_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ng1136","volume":"34","author":"S Jamain","year":"2003","unstructured":"Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003; 34: 27\u201329.","journal-title":"Nat Genet"},{"key":"BFtp2012124_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.conb.2009.06.003","volume":"19","author":"T Bourgeron","year":"2009","unstructured":"Bourgeron T . A synaptic trek to autism. Curr Opin Neurobiol 2009; 19: 231\u2013234.","journal-title":"Curr Opin Neurobiol"},{"key":"BFtp2012124_CR9","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1086\/382137","volume":"74","author":"F Laumonnier","year":"2004","unstructured":"Laumonnier F, Bonnet-Brilhault F, Gomot M, Blanc R, David A, Moizard MP et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 2004; 74: 552\u2013557.","journal-title":"Am J Hum Genet"},{"key":"BFtp2012124_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ajhg.2010.01.011","volume":"86","author":"M Giannandrea","year":"2010","unstructured":"Giannandrea M, Bianchi V, Mignogna ML, Sirri A, Carrabino S, D'Elia E et al. Mutations in the Small GTPase Gene RAB39B are responsible for x-linked mental retardation associated with autism, epilepsy, and macrocephaly. Am J Hum Genet 2010; 86: 185\u2013195.","journal-title":"Am J Hum Genet"},{"key":"BFtp2012124_CR11","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1586\/erm.09.59","volume":"9","author":"LA Weiss","year":"2009","unstructured":"Weiss LA . Autism genetics: emerging data from genome-wide copy-number and single nucleotide polymorphism scans. Expert Rev Mol Diagn 2009; 9: 795\u2013803.","journal-title":"Expert Rev Mol Diagn"},{"key":"BFtp2012124_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1126\/science.1146221","volume":"318","author":"K Tabuchi","year":"2007","unstructured":"Tabuchi K, Blundell J, Etherton MR, Hammer RE, Liu X, Powell CM et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007; 318: 71\u201376.","journal-title":"Science"},{"key":"BFtp2012124_CR13","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.neuron.2007.05.029","volume":"54","author":"AA Chubykin","year":"2007","unstructured":"Chubykin AA, Atasoy D, Etherton MR, Brose N, Kavalali ET, Gibson JR et al. Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2. Neuron 2007; 54: 919\u2013931.","journal-title":"Neuron"},{"key":"BFtp2012124_CR14","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1001\/archgenpsychiatry.2011.73","volume":"68","author":"L Croen","year":"2011","unstructured":"Croen L, Grether JK, Yoshida CK, Odouli R, Hendrick V . Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch General Psychiatry 2011; 68: 1104\u20131112.","journal-title":"Arch General Psychiatry"},{"key":"BFtp2012124_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.bbr.2008.12.016","volume":"204","author":"PH Patterson","year":"2009","unstructured":"Patterson PH . Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res 2009; 204: 313\u2013321.","journal-title":"Behav Brain Res"},{"key":"BFtp2012124_CR16","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/00005072-199807000-00001","volume":"57","author":"TL Kemper","year":"1998","unstructured":"Kemper TL, Bauman M . Neuropathology of infantile autism. J Neuropathol Exp Neurol 1998; 57: 645\u2013652.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFtp2012124_CR17","unstructured":"Dossche DM . GABA in autism. international review of neurobiology., vol. 71. Academic Press: Amsterdam 2005 pp 1\u2013481."},{"key":"BFtp2012124_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nature09582","volume":"468","author":"HT Chao","year":"2010","unstructured":"Chao HT, Chen HM, Samaco RC, Xue MS, Chahrour M, Yoo J et al. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes 1. Nature 2010; 468: 263\u2013269.","journal-title":"Nature"},{"key":"BFtp2012124_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.neuron.2010.04.008","volume":"66","author":"C Zhang","year":"2010","unstructured":"Zhang C, Atasoy D, Arac D, Yang X, Fucillo MV, Robison AJ et al. Neurexins physically and functionally interact with GABA(A) receptors. Neuron 2010; 66: 403\u2013416.","journal-title":"Neuron"},{"key":"BFtp2012124_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/297153","volume":"297","author":"R Pizzarelli","year":"2011","unstructured":"Pizzarelli R, Cherubini E . Alterations of gabaergic signaling in autsim spectrum disorders. Neural Plast 2011; 297: 1\u201312.","journal-title":"Neural Plast"},{"key":"BFtp2012124_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s11689-009-9023-x","volume":"1","author":"N Gogolla","year":"2009","unstructured":"Gogolla N, LeBlanc JJ, Quast KB, Sudhof TC, Fagiolini M, Hensch TK . Common circuit defect of excitatory-inhibitory balance in mouse models of autism 1. J Neurodev Disord 2009; 1: 172\u2013181.","journal-title":"J Neurodev Disord"},{"key":"BFtp2012124_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1146\/annurev.ph.55.030193.002025","volume":"55","author":"W Singer","year":"1993","unstructured":"Singer W . Synchronization of cortical activity and its putative role in information-processing and learning 21. Annu Rev Physiol 1993; 55: 349\u2013374.","journal-title":"Annu Rev Physiol"},{"key":"BFtp2012124_CR23","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1126\/science.7878473","volume":"267","author":"JE Lisman","year":"1995","unstructured":"Lisman JE, Idiart MAP . Storage of 7+\/\u22122 short-term memories in oscillatory subcycles 1. Science 1995; 267: 1512\u20131515.","journal-title":"Science"},{"key":"BFtp2012124_CR24","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.1073\/pnas.89.12.5670","volume":"89","author":"VN Murthy","year":"1992","unstructured":"Murthy VN, Fetz EE . Coherent 25-Hz to 35-Hz oscillations in the sensorimotor cortex of awake behaving monkeys 1. Proc Natl Acad Sci USA 1992; 89: 5670\u20135674.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtp2012124_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/nrn1648","volume":"6","author":"DA Lewis","year":"2005","unstructured":"Lewis DA, Hashimoto T, Volk DW . Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 2005; 6: 312\u2013324.","journal-title":"Nat Rev Neurosci"},{"key":"BFtp2012124_CR26","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.tins.2008.02.005","volume":"31","author":"JE Lisman","year":"2008","unstructured":"Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 2008; 31: 234\u2013242.","journal-title":"Trends Neurosci"},{"key":"BFtp2012124_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s11689-009-9023-x","volume":"1","author":"N Gogolla","year":"2009","unstructured":"Gogolla N, LeBlanc JJ, Quast KB, Sudhof TC, Fagiolini M, Hensch TK . Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J Neurodev Disord 2009; 1: 172\u2013181.","journal-title":"J Neurodev Disord"},{"key":"BFtp2012124_CR28","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1097\/00001756-200108280-00021","volume":"12","author":"SJ Grice","year":"2001","unstructured":"Grice SJ, Spratling MW, Karmiloff-Smith A, Halit H, Csibra G, de Haan M et al. Disordered visual processing and oscillatory brain activity in autism and Williams syndrome. Neuroreport 2001; 12: 2697\u20132700.","journal-title":"Neuroreport"},{"key":"BFtp2012124_CR29","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0010-9452(08)70273-9","volume":"41","author":"C Brown","year":"2005","unstructured":"Brown C, Gruber T, Boucher J, Rippon G, Brock J . Gamma abnormalities during perception of illusory figures in autism. Cortex 2005; 41: 364\u2013376.","journal-title":"Cortex"},{"key":"BFtp2012124_CR30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.biopsych.2006.07.002","volume":"62","author":"TW Wilson","year":"2007","unstructured":"Wilson TW, Rojas DC, Reite ML, Teale PD, Rogers SJ . Children and adolescents with autism exhibit reduced MEG steady-state gamma responses. Biol Psychiatry 2007; 62: 192\u2013197.","journal-title":"Biol Psychiatry"},{"issue":"6","key":"BFtp2012124_CR31","doi-asserted-by":"publisher","first-page":"e39127","DOI":"10.1371\/journal.pone.0039127","volume":"7","author":"Adrienne L. Tierney","year":"2012","unstructured":"Tierney AL, Gabard-Durnam L, Vogel-Farley V, Tager-Flusberg H, Nelson CA . Developmental trajectories of resting EEG power: an endophenotype of autism spectrum disorder. Plos One 2012; 7 (6).","journal-title":"PLoS ONE"},{"key":"BFtp2012124_CR32","first-page":"355","volume":"2","author":"F Marrosu","year":"1987","unstructured":"Marrosu F, Marrosu G, Rachel M, Biggio G . Paradoxical reactions elicited by diazepam in children with classic autism. Funct Neurol 1987; 2: 355\u2013361.","journal-title":"Funct Neurol"},{"key":"BFtp2012124_CR33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1192\/bjp.176.4.357","volume":"176","author":"L Wing","year":"2000","unstructured":"Wing L, Shah A . Catatonia in autistic spectrum disorders. Br J Psychiatry 2000; 176: 357\u2013362.","journal-title":"Br J Psychiatry"},{"key":"BFtp2012124_CR34","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1177\/1362361308091650","volume":"12","author":"J Hutton","year":"2008","unstructured":"Hutton J, Goode S, Murphy M, Le Couteur A, Rutter M . New-onset psychiatric disorders in individuals with autism. Autism 2008; 12: 373\u2013390.","journal-title":"Autism"},{"key":"BFtp2012124_CR35","doi-asserted-by":"publisher","first-page":"I31","DOI":"10.1007\/PL00014198","volume":"251","author":"GS Ungvari","year":"2001","unstructured":"Ungvari GS, Kau LS, Wai-Kwong T, Shing NF . The pharmacological treatment of catatonia: an overview. Eur Arch Psychiatry Clin Neurosci 2001; 251: I31\u2013I34.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"BFtp2012124_CR36","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.pnpbp.2010.08.017","volume":"34","author":"P Tibrewal","year":"2010","unstructured":"Tibrewal P, Narayanaswamy J, Zutshi A, Srinivasaraju R, Math SB . Response rate of lorazepam in catatonia: A developing country's perspective. Prog Neuro-Psych Biol Psych 2010; 34: 1520\u20131522.","journal-title":"Prog Neuro-Psych Biol Psych"},{"key":"BFtp2012124_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0074-7742(05)72014-6","volume":"72","author":"M Fink","year":"2006","unstructured":"Fink M, Taylor MA, Ghaziuddin N . Catatonia in autistic spectrum disorders: a medical treatment algorithm. Int Rev Neurobiol 2006; 72: 233\u2013244.","journal-title":"Int Rev Neurobiol"},{"key":"BFtp2012124_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1365-2788.2005.00666.x","volume":"49","author":"M Ghaziuddin","year":"2005","unstructured":"Ghaziuddin M, Quinlan P, Ghaziuddin N . Catatonia in autism: a distinct subtype? J Intellectual Disabil Res 2005; 49: 102\u2013105.","journal-title":"J Intellectual Disabil Res"},{"key":"BFtp2012124_CR39","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ijpsycho.2008.05.496","volume":"69","author":"EV Orekhova","year":"2008","unstructured":"Orekhova EV, Stroganova TA, Prokofiev AO, Nygren G, Gillberg C, Elam M . Right hemispheric failure to respond to temporal novelty in autism: evidence from an event-related potential study. Int J Psychophysiol 2008; 69: 186.","journal-title":"Int J Psychophysiol"},{"key":"BFtp2012124_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.brs.2011.02.001","volume":"5","author":"PG Enticott","year":"2012","unstructured":"Enticott PG, Rinehart NJ, Tonge BJ, Bradshaw JL, Fitzgerald PB . Repetitive transcranial magnetic stimulation (rTMS) improves movement-related cortical potentials in autism spectrum disorders. Brain Stimulation 2012; 5: 30\u201337.","journal-title":"Brain Stimulation"},{"key":"BFtp2012124_CR41","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1056\/NEJM199908123410704","volume":"341","author":"MJ Painter","year":"1999","unstructured":"Painter MJ, Scher MS, Stein AD, Armatti S, Wang ZM, Gardiner JC et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med 1999; 341: 485\u2013489.","journal-title":"N Engl J Med"},{"key":"BFtp2012124_CR42","doi-asserted-by":"publisher","first-page":"F165","DOI":"10.1136\/fn.86.3.F165","volume":"86","author":"GB Boylan","year":"2002","unstructured":"Boylan GB, Rennie JM, Pressler RM, Wilson G, Morton M, Binnie CD . Phenobarbitone neonatal seizures, and video-EEG. Arch Dis Child Fetal Neonatal Ed 2002; 86: F165\u2013F170.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"BFtp2012124_CR43","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1177\/0883073807301917","volume":"22","author":"R Guillet","year":"2007","unstructured":"Guillet R, Kwon J . Seizure recurrence and developmental disabilities after neonatal seizures: outcomes are unrelated to use of phenobarbital prophylaxis. J Child Neurol 2007; 22: 389\u2013395.","journal-title":"J Child Neurol"},{"key":"BFtp2012124_CR44","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1074\/mcp.M800030-MCP200","volume":"7","author":"AM Kaindl","year":"2008","unstructured":"Kaindl AM, Koppelstaetter A, Nebrich G, Stuwe J, Sifringer M, Zabel C et al. Brief alteration of NMDA or GABAA receptor-mediated neurotransmission has long term effects on the developing cerebral cortex. Mol Cell Proteomics 2008; 7: 2293\u20132310.","journal-title":"Mol Cell Proteomics"},{"key":"BFtp2012124_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1528-1167.2006.00378.x","volume":"47","author":"G Huberfeld","year":"2006","unstructured":"Huberfeld G, Wittner L, Clemenceau S, Baulac M, Miles R, Kaila K et al. Perturbed expression of the K-Cl cotransporter KCC2 and GABAergic signalling in human temporal lobe epilepsy. Epilepsia 2006; 47: 9.","journal-title":"Epilepsia"},{"key":"BFtp2012124_CR46","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1126\/science.1076510","volume":"298","author":"I Cohen","year":"2002","unstructured":"Cohen I, Navarro V, Clemenceau S, Baulac M, Miles R . On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science 2002; 298: 1418\u20131421.","journal-title":"Science"},{"key":"BFtp2012124_CR47","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/brain\/awr041","volume":"134","author":"R Nardou","year":"2011","unstructured":"Nardou R, Yamamoto S, Chazal G, Bhar A, Ferrand N, Dulac O et al. Neuronal chloride accumulation and excitatory GABA underlie aggravation of neonatal epileptiform activities by phenobarbital. Brain 2011; 134: 987\u20131002.","journal-title":"Brain"},{"key":"BFtp2012124_CR48","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1152\/physrev.00017.2006","volume":"87","author":"Y Ben Ari","year":"2007","unstructured":"Ben Ari Y, Gaiarsa JL, Tyzio R, Khazipov R . GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol Rev 2007; 87: 1215\u20131284.","journal-title":"Physiol Rev"},{"key":"BFtp2012124_CR49","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/nm1301","volume":"11","author":"VI Dzhala","year":"2005","unstructured":"Dzhala VI, Talos DM, Sdrulla DA, Brumback AC, Mathews GC, Benke TA et al. NKCC1 transporter facilitates seizures in the developing brain. Nat Med 2005; 11: 1205\u20131213.","journal-title":"Nat Med"},{"key":"BFtp2012124_CR50","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0166-2236(03)00068-7","volume":"26","author":"JA Payne","year":"2003","unstructured":"Payne JA, Rivera C, Voipio J, Kaila K . Cation-chloride co-transporters in neuronal communication, development and trauma. Trends Neurosci 2003; 26: 199\u2013206.","journal-title":"Trends Neurosci"},{"key":"BFtp2012124_CR51","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/16697","volume":"397","author":"C Rivera","year":"1999","unstructured":"Rivera C, Voipio J, Payne JA, Ruusuvuori E, Lahtinen H, Lamsa K et al. The K+\/Cl\u2212 co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature 1999; 397: 251\u2013255.","journal-title":"Nature"},{"key":"BFtp2012124_CR52","first-page":"309","volume":"15","author":"E Delpire","year":"2000","unstructured":"Delpire E . Cation-chloride cotransporters in neuronal communication. News Physiol Sci 2000; 15: 309\u2013312.","journal-title":"News Physiol Sci"},{"key":"BFtp2012124_CR53","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/j.1552-4604.1981.tb05661.x","volume":"21","author":"PW Feit","year":"1981","unstructured":"Feit PW . Bumetanide--the way to its chemical structure. J Clin Pharmacol 1981; 21: 531\u2013536.","journal-title":"J Clin Pharmacol"},{"key":"BFtp2012124_CR54","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1146\/annurev.physiol.64.081501.155847","volume":"64","author":"E Delpire","year":"2002","unstructured":"Delpire E, Mount DB . Human and murine phenotypes associated with defects in cation-chloride cotransport. Annu Rev Physiol 2002; 64: 803\u2013843.","journal-title":"Annu Rev Physiol"},{"key":"BFtp2012124_CR55","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neuron.2009.03.003","volume":"61","author":"P Blaesse","year":"2009","unstructured":"Blaesse P, Airaksinen MS, Rivera C, Kaila K . Cation-chloride cotransporters and neuronal function. Neuron 2009; 61: 820\u2013838.","journal-title":"Neuron"},{"key":"BFtp2012124_CR56","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0009-9236(96)90199-X","volume":"60","author":"JE Sullivan","year":"1996","unstructured":"Sullivan JE, Witte MK, Yamashita TS, Myers CM, Blumer JL . Dose-ranging evaluation of bumetanide pharmacodynamics in critically ill infants. Clin Pharmacol Ther 1996; 60: 424\u2013434.","journal-title":"Clin Pharmacol Ther"},{"key":"BFtp2012124_CR57","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/BF02212936","volume":"19","author":"A Le Couteur","year":"1989","unstructured":"Le Couteur A, Rutter M, Lord C, Rios P, Robertson S, Holdgrafer M et al. Autism diagnostic interview: a standardized investigator-based instrument. J Autism Dev Disord 1989; 19: 363\u2013387.","journal-title":"J Autism Dev Disord"},{"key":"BFtp2012124_CR58","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/BF02408436","volume":"10","author":"E Schopler","year":"1980","unstructured":"Schopler E, Reichler RJ, DeVellis RF, Daly K . Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). J Autism Dev Disord 1980; 10: 91\u2013103.","journal-title":"J Autism Dev Disord"},{"key":"BFtp2012124_CR59","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/BF02172092","volume":"24","author":"DL DiLalla","year":"1994","unstructured":"DiLalla DL, Rogers SJ . Domains of the Childhood Autism Rating Scale: relevance for diagnosis and treatment. J Autism Dev Disord 1994; 24: 115\u2013128.","journal-title":"J Autism Dev Disord"},{"key":"BFtp2012124_CR60","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2165\/00023210-200923060-00005","volume":"23","author":"G Masi","year":"2009","unstructured":"Masi G, Cosenza A, Millepiedi S, Muratori F, Pari C, Salvadori F . Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study. CNS Drugs 2009; 23: 511\u2013521.","journal-title":"CNS Drugs"},{"key":"BFtp2012124_CR61","doi-asserted-by":"publisher","first-page":"I15","DOI":"10.12659\/MSM.881792","volume":"17","author":"DA Geier","year":"2011","unstructured":"Geier DA, Kern JK, Davis G, King PG, Adams JB, Young JL et al. A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders. Med Sci Monit 2011; 17: I15\u2013I23.","journal-title":"Med Sci Monit"},{"key":"BFtp2012124_CR62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pnpbp.2010.10.015","volume":"35","author":"R Canitano","year":"2011","unstructured":"Canitano R, Scandurra V . Psychopharmacology in autism: an update. Prog Neuro-Psych Biol Psych 2011; 35: 18\u201328.","journal-title":"Prog Neuro-Psych Biol Psych"},{"key":"BFtp2012124_CR63","volume-title":"Assessment Manual for Psychopharmacology. Early Clinical Drug Evaluation Unit","author":"W Guy","year":"2000","unstructured":"Guy W . Assessment Manual for Psychopharmacology. Early Clinical Drug Evaluation Unit. National institute of mental health: Washington, DC, 2000."},{"key":"BFtp2012124_CR64","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/16051","volume":"2","author":"JC Crowley","year":"1999","unstructured":"Crowley JC, Katz LC . Development of ocular dominance columns in the absence of retinal input. Nat Neurosci 1999; 2: 1125\u20131130.","journal-title":"Nat Neurosci"},{"key":"BFtp2012124_CR65","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1097\/00004583-200111000-00009","volume":"40","author":"T Owley","year":"2001","unstructured":"Owley T, McMahon W, Cook EH, Laulhere T, South M, Mays LZ et al. Multisite, double-blind, placebo-controlled trial of porcine secretin in autism. J Am Acad Child Adolesc Psychiatry 2001; 40: 1293\u20131299.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BFtp2012124_CR66","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ejpn.2011.02.004","volume":"15","author":"AS Papauasiliou","year":"2011","unstructured":"Papauasiliou AS, Nikaina I, Rizou J, Alexandrou S . The effect of a psycho-educational program on CARS scores and short sensory profile in autistic children. Eur J Paediatr Neurol 2011; 15: 338\u2013344.","journal-title":"Eur J Paediatr Neurol"},{"key":"BFtp2012124_CR67","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1097\/00004583-200110000-00015","volume":"40","author":"G Masi","year":"2001","unstructured":"Masi G, Cosenza A, Mucci M, Brovedani P . Open trial of risperidone in 24 young children with pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry 2001; 40: 1206\u20131214.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BFtp2012124_CR68","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1177\/08830738060210060801","volume":"21","author":"R Nagaraj","year":"2006","unstructured":"Nagaraj R, Singhi P, Malhi P . Risperidone in children with autism: randomized, placebo-controlled, double-blind study. J Child Neurol 2006; 21: 450\u2013455.","journal-title":"J Child Neurol"},{"key":"BFtp2012124_CR69","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2147\/NDT.S1450","volume":"4","author":"R Canitano","year":"2008","unstructured":"Canitano R, Scandurra V . Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents. Neuropsychiatr Dis Treat 2008; 4: 723\u2013730.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"BFtp2012124_CR70","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1089\/cap.2006.16.575","volume":"16","author":"J Luby","year":"2006","unstructured":"Luby J, Mrakotsky C, Stalets MM, Belden A, Heffelfinger A, Williams M et al. Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy. J Child Adolesc Psychopharmacol 2006; 16: 575\u2013587.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"BFtp2012124_CR71","doi-asserted-by":"publisher","first-page":"E634","DOI":"10.1542\/peds.2003-0264-F","volume":"114","author":"S Shea","year":"2004","unstructured":"Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I et al. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 2004; 114: E634\u2013E641.","journal-title":"Pediatrics"},{"key":"BFtp2012124_CR72","first-page":"S72","volume":"30","author":"CJ McDougle","year":"2005","unstructured":"McDougle CJ, Stigler KA, Posey DJ . Pharmacological treatment of behavioral symptoms in autism. Neuropsychopharmacology 2005; 30: S72.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp2012124_CR73","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1089\/cap.2006.16.379","volume":"16","author":"GJ Pandina","year":"2006","unstructured":"Pandina GJ, Aman MG, Findling RL . Risperidone in the management of disruptive behavior disorders. J Child Adolesc Psychopharmacol 2006; 16: 379\u2013392.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"BFtp2012124_CR74","doi-asserted-by":"crossref","unstructured":"Robb AS, Andersson C, Bellocchio EE, Manos G, Rojas-Fernandez C, Mathew S et al. Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6-17 years old):results from a pooled analysis of 2 studies. Prim Care Companion CNS Disord 2011; 13 (1).","DOI":"10.4088\/PCC.10m01008gry"},{"key":"BFtp2012124_CR75","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11920-010-0172-0","volume":"13","author":"TD Benton","year":"2011","unstructured":"Benton TD . Aripiprazole to treat irritability associated with autism: a placebo-controlled, fixed-dose trial. Curr Psychiatry Rep 2011; 13: 77\u201379.","journal-title":"Curr Psychiatry Rep"},{"key":"BFtp2012124_CR76","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.4088\/JCP.09m05933","volume":"72","author":"RN Marcus","year":"2011","unstructured":"Marcus RN, Owen R, Manos G, Mankoski R, Kamen L, McQuade RD et al. Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study. J Clin Psychiatry 2011; 72: 1270\u20131276.","journal-title":"J Clin Psychiatry"},{"key":"BFtp2012124_CR77","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/BF00916315","volume":"21","author":"RC Eaves","year":"1993","unstructured":"Eaves RC, Milner B . The criterion-related validity of the childhood autism rating-scale and the autism behavior checklist. J Abnorm Child Psychol 1993; 21: 481\u2013491.","journal-title":"J Abnorm Child Psychol"},{"key":"BFtp2012124_CR78","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s10803-006-0128-8","volume":"36","author":"PE Ventola","year":"2006","unstructured":"Ventola PE, Kleinman J, Pandey J, Barton M, Allen S, Green J et al. Agreement among four diagnostic instruments for autism spectrum disorders in toddlers. J Autism Dev Disord 2006; 36: 839\u2013847.","journal-title":"J Autism Dev Disord"},{"key":"BFtp2012124_CR79","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10803-005-0006-9","volume":"35","author":"A Perry","year":"2005","unstructured":"Perry A, Condillac RA, Freeman NL, Dunn-Geier J, Belair J . Multi-site study of the childhood autism rating scale (CARS) in five clinical groups of young children. J Autism Dev Disord 2005; 35: 625\u2013634.","journal-title":"J Autism Dev Disord"},{"key":"BFtp2012124_CR80","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1126\/science.1086446","volume":"302","author":"WG Chen","year":"2003","unstructured":"Chen WG, Chang Q, Lin YX, Meissner A, West AE, Griffith EC et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 2003; 302: 885\u2013889.","journal-title":"Science"},{"key":"BFtp2012124_CR81","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1083\/jcb.200209011","volume":"159","author":"C Rivera","year":"2002","unstructured":"Rivera C, Li H, Thomas-Crusells J, Lahtinen H, Viitanen T, Nanobashvili A et al. BDNF-induced TrkB activation down-regulates the K+-Cl- cotransporter KCC2 and impairs neuronal Cl- extrusion. J Cell Biol 2002; 159: 747\u2013752.","journal-title":"J Cell Biol"},{"key":"BFtp2012124_CR82","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1523\/JNEUROSCI.2006-10.2011","volume":"31","author":"A Ludwig","year":"2011","unstructured":"Ludwig A, Uvarov P, Soni S, Thomas-Crusells J, Airaksinen MS, Rivera C . Early growth response 4 mediates bdnf induction of potassium chloride cotransporter 2 transcription. J Neurosci 2011; 31: 644\u2013649.","journal-title":"J Neurosci"},{"key":"BFtp2012124_CR83","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.neuroscience.2010.06.069","volume":"170","author":"FI Roullet","year":"2010","unstructured":"Roullet FI, Wollaston L, deCatanzaro D, Foster JA . Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid. Neuroscience 2010; 170: 514\u2013522.","journal-title":"Neuroscience"},{"key":"BFtp2012124_CR84","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1126\/science.1090842","volume":"302","author":"K Martinowich","year":"2003","unstructured":"Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y et al. DNA methylation-related chromatin remodeling in activity-dependent Bdnf gene regulation. Science 2003; 302: 890\u2013893.","journal-title":"Science"},{"key":"BFtp2012124_CR85","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.1153252","volume":"320","author":"M Chahrour","year":"2008","unstructured":"Chahrour M, Jung SY, Shaw C, Zhou XB, Wong STC, Qin J et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008; 320: 1224\u20131229.","journal-title":"Science"},{"key":"BFtp2012124_CR86","doi-asserted-by":"publisher","first-page":"475","DOI":"10.4161\/chan.5.6.17952","volume":"5","author":"TZ Deeb","year":"2011","unstructured":"Deeb TZ, Lee HHC, Walker JA, Davies PA, Moss SJ . Hyperpolarizing GABA ergic transmission depends on KCC2 function and membrane potential. Channels 2011; 5: 475\u2013481.","journal-title":"Channels"},{"key":"BFtp2012124_CR87","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1113\/jphysiol.2006.107086","volume":"573","author":"ST Sipila","year":"2006","unstructured":"Sipila ST, Schuchmann S, Voipio J, Yamada J, Kaila K . The cation-chloride cotransporter NKCC1 promotes sharp waves in the neonatal rat hippocampus. J Physiol 2006; 573: 765\u2013773.","journal-title":"J Physiol"},{"key":"BFtp2012124_CR88","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jchromb.2011.02.018","volume":"879","author":"YJ Li","year":"2011","unstructured":"Li YJ, Cleary R, Kellogg M, Soul JS, Berry GT, Jensen FE . Sensitive isotope dilution liquid chromatography\/tandem mass spectrometry method for quantitative analysis of bumetanide in serum and brain tissue. J Chromatogr B 2011; 879: 998\u20131002.","journal-title":"J Chromatogr B"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/tp2012124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/tp2012124","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2012124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T16:45:21Z","timestamp":1672937121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp2012124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,11]]},"references-count":88,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12]]}},"alternative-id":["BFtp2012124"],"URL":"https:\/\/doi.org\/10.1038\/tp.2012.124","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717977190.793471698","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717977190.793470713","asserted-by":"object"}]},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,11]]},"assertion":[{"value":"4 October 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the authors have no conflict of interest, no financial and personal relationships with other people or organisations including employment, consultancies, stock ownership, honoraria, paid expert testimony, and travel grants all during the conduction and termination of the work submitted. An application patent on the use of diuretics has been deposited by the French medical research council on the basis of our clinical results. Subsequent to completion of this study (finished in June 2010), one of the authors (Y B-A) has become (in 2012) the CEO and a major shareholder of a company (Neurochlore), seeking to develop and commercialize bumetanide as a treatment for autism.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}